Single-dose administration of therapeutic divalent siRNA targeting MECP2 prevents lethality for one year in an MECP2 duplication mouse model.
Saved in:
| Title: | Single-dose administration of therapeutic divalent siRNA targeting MECP2 prevents lethality for one year in an MECP2 duplication mouse model. |
|---|---|
| Authors: | Hariharan VN; RNA Therapeutic Institute, University of Massachusetts Chan Medical School; Worcester, United States of America., Summers A; RNA Therapeutic Institute, University of Massachusetts Chan Medical School; Worcester, United States of America., Clipperton-Allen AE; The Jackson Laboratory; Bar Harbor, United States of America., Caiazzi J; RNA Therapeutic Institute, University of Massachusetts Chan Medical School; Worcester, United States of America., Hildebrand SR; RNA Therapeutic Institute, University of Massachusetts Chan Medical School; Worcester, United States of America., O'Reilly D; RNA Therapeutic Institute, University of Massachusetts Chan Medical School; Worcester, United States of America., Tang Q; RNA Therapeutic Institute, University of Massachusetts Chan Medical School; Worcester, United States of America., Kennedy Z; RNA Therapeutic Institute, University of Massachusetts Chan Medical School; Worcester, United States of America., Echeverria D; RNA Therapeutic Institute, University of Massachusetts Chan Medical School; Worcester, United States of America., McHugh N; RNA Therapeutic Institute, University of Massachusetts Chan Medical School; Worcester, United States of America., Cooper D; RNA Therapeutic Institute, University of Massachusetts Chan Medical School; Worcester, United States of America., Souza J; RNA Therapeutic Institute, University of Massachusetts Chan Medical School; Worcester, United States of America., Ferguson C; RNA Therapeutic Institute, University of Massachusetts Chan Medical School; Worcester, United States of America., Bogdanik L; The Jackson Laboratory; Bar Harbor, United States of America., Coenraads M; The Rett Syndrome Research Trust; Trumbull, United States of America., Khvorova A; RNA Therapeutic Institute, University of Massachusetts Chan Medical School; Worcester, United States of America. |
| Source: | BioRxiv : the preprint server for biology [bioRxiv] 2025 Mar 29. Date of Electronic Publication: 2025 Mar 29. |
| Publication Type: | Journal Article; Preprint |
| Journal Info: | Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40196492 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Single-dose administration of therapeutic divalent siRNA targeting MECP2 prevents lethality for one year in an MECP2 duplication mouse model. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Hariharan+VN%22">Hariharan VN</searchLink>; RNA Therapeutic Institute, University of Massachusetts Chan Medical School; Worcester, United States of America.<br /><searchLink fieldCode="AU" term="%22Summers+A%22">Summers A</searchLink>; RNA Therapeutic Institute, University of Massachusetts Chan Medical School; Worcester, United States of America.<br /><searchLink fieldCode="AU" term="%22Clipperton-Allen+AE%22">Clipperton-Allen AE</searchLink>; The Jackson Laboratory; Bar Harbor, United States of America.<br /><searchLink fieldCode="AU" term="%22Caiazzi+J%22">Caiazzi J</searchLink>; RNA Therapeutic Institute, University of Massachusetts Chan Medical School; Worcester, United States of America.<br /><searchLink fieldCode="AU" term="%22Hildebrand+SR%22">Hildebrand SR</searchLink>; RNA Therapeutic Institute, University of Massachusetts Chan Medical School; Worcester, United States of America.<br /><searchLink fieldCode="AU" term="%22O'Reilly+D%22">O'Reilly D</searchLink>; RNA Therapeutic Institute, University of Massachusetts Chan Medical School; Worcester, United States of America.<br /><searchLink fieldCode="AU" term="%22Tang+Q%22">Tang Q</searchLink>; RNA Therapeutic Institute, University of Massachusetts Chan Medical School; Worcester, United States of America.<br /><searchLink fieldCode="AU" term="%22Kennedy+Z%22">Kennedy Z</searchLink>; RNA Therapeutic Institute, University of Massachusetts Chan Medical School; Worcester, United States of America.<br /><searchLink fieldCode="AU" term="%22Echeverria+D%22">Echeverria D</searchLink>; RNA Therapeutic Institute, University of Massachusetts Chan Medical School; Worcester, United States of America.<br /><searchLink fieldCode="AU" term="%22McHugh+N%22">McHugh N</searchLink>; RNA Therapeutic Institute, University of Massachusetts Chan Medical School; Worcester, United States of America.<br /><searchLink fieldCode="AU" term="%22Cooper+D%22">Cooper D</searchLink>; RNA Therapeutic Institute, University of Massachusetts Chan Medical School; Worcester, United States of America.<br /><searchLink fieldCode="AU" term="%22Souza+J%22">Souza J</searchLink>; RNA Therapeutic Institute, University of Massachusetts Chan Medical School; Worcester, United States of America.<br /><searchLink fieldCode="AU" term="%22Ferguson+C%22">Ferguson C</searchLink>; RNA Therapeutic Institute, University of Massachusetts Chan Medical School; Worcester, United States of America.<br /><searchLink fieldCode="AU" term="%22Bogdanik+L%22">Bogdanik L</searchLink>; The Jackson Laboratory; Bar Harbor, United States of America.<br /><searchLink fieldCode="AU" term="%22Coenraads+M%22">Coenraads M</searchLink>; The Rett Syndrome Research Trust; Trumbull, United States of America.<br /><searchLink fieldCode="AU" term="%22Khvorova+A%22">Khvorova A</searchLink>; RNA Therapeutic Institute, University of Massachusetts Chan Medical School; Worcester, United States of America. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101680187%22">BioRxiv : the preprint server for biology</searchLink> [bioRxiv] 2025 Mar 29. <i>Date of Electronic Publication: </i>2025 Mar 29. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Preprint – Name: TitleSource Label: Journal Info Group: Src Data: <i>Country of Publication: </i>United States <i>NLM ID: </i>101680187 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2692-8205 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2226928205%22">26928205 </searchLink><i>NLM ISO Abbreviation: </i>bioRxiv <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40196492 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1101/2025.03.26.645328 Languages: – Code: eng Text: English Titles: – TitleFull: Single-dose administration of therapeutic divalent siRNA targeting MECP2 prevents lethality for one year in an MECP2 duplication mouse model. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Hariharan VN – PersonEntity: Name: NameFull: Summers A – PersonEntity: Name: NameFull: Clipperton-Allen AE – PersonEntity: Name: NameFull: Caiazzi J – PersonEntity: Name: NameFull: Hildebrand SR – PersonEntity: Name: NameFull: O'Reilly D – PersonEntity: Name: NameFull: Tang Q – PersonEntity: Name: NameFull: Kennedy Z – PersonEntity: Name: NameFull: Echeverria D – PersonEntity: Name: NameFull: McHugh N – PersonEntity: Name: NameFull: Cooper D – PersonEntity: Name: NameFull: Souza J – PersonEntity: Name: NameFull: Ferguson C – PersonEntity: Name: NameFull: Bogdanik L – PersonEntity: Name: NameFull: Coenraads M – PersonEntity: Name: NameFull: Khvorova A IsPartOfRelationships: – BibEntity: Dates: – D: 29 M: 03 Text: 2025 Mar 29 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 2692-8205 Titles: – TitleFull: BioRxiv : the preprint server for biology Type: main |
| ResultId | 1 |